Inorganic nanoparticles (NPs) show great potential for medicinal therapy. However, biocompatibility studies are essential to determine if they are safe.
In this paper Diaz et al studied five different NPs, and they compared the cytotoxicity, internalization, aggregation in medium, and reactive oxygen species (ROS) production, using different tumoral and normal human blood cells.
The reported results mainly reveal that effects not only depend on the material used but equally on the cell type used. For instance, while all NPs are phagocytosed and induce ROS in mouse macrophages, they behave differently on human peripheral blood cells, both in respect to internalization and ROS induction.
Moreover, while in some instances the toxicity and ROS were positively correlated this could not be found in others.
Therefore differences depending on the cell type used are important and should be taken into account in standardizing the procedures for the evaluation of the toxicity (safety).
This paper is important because the physico-chemical characterization of the materials is often thought to be the main aspect in producing comparable data. The biological model, protocol, used is somewhat forgotten. This study underlines the importance of good biological characterization of toxicity studies.